The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  January 2018 Next

Advisory Board

Hans Ulrich STILZ (Novo Nordisk, Denmark)

AB Members

Annette G. BECK-SICKINGER, (Leipzig University, Germany)
Karin BRINER (Novartis, USA)
Stuart CONWAY (University of Oxford, UK)
François DIEDERICH (ETH Zürich, Switzerland)
Frank LEEMHUIS (Mercachem, The Netherlands)
Ulrich SCHUBERT (TU Wien, Austria) 

The Advisory Board is an EFMC consulting body for the executive committee assisting in assessing the Federation's strategic goals. The tasks of the AB consists of:

• advising on EFMC policy related matters internally and externally
• proposing novel scientific or political initiatives to the Executive Committee
• proposing strategies how to increase awareness of Medicinal Chemistry and support of the community in Europe
• proposing strategies how to affect and interact with stakeholders in Europe
The AB is composed of eminent scientists in the life sciences and medicinal chemistry and is chaired by the past president.

Job portal

Synthetic Organic and Medicinal Chemists, Vernalis Research: Chemistry, Cambridge, United Kingdom
read more

Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck